Telesis Bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.48
|
-0.42
|
0.06
|
12.50%
|
|
2022-06-30
|
-0.51
|
-0.50
|
0.01
|
1.96%
|
|
2022-03-31
|
-0.43
|
-0.45
|
-0.02
|
-4.65%
|
|
2021-12-31
|
-0.37
|
-0.43
|
-0.06
|
-16.22%
|
|
2021-09-30
|
-0.28
|
-0.34
|
-0.06
|
-21.43%
|
|
2021-06-30
|
-0.23
|
0.21
|
0.44
|
191.30%
|
|
2021-03-31
|
-0.07
|
0.34
|
0.41
|
585.71%
|
|
2020-12-31
|
-0.24
|
-0.22
|
0.02
|
8.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-09-30
|
-1.37
|
|
2021-12-31
|
-0.22
|
|
2020-12-31
|
-0.81
|
|
2019-12-31
|
-2.20
|
|
2018-12-31
|
-4.04
|